ArticleOncotarget2017

Idelalisib and bendamustine combination is synergistic and increases DNA damage response in chronic lymphocytic leukemia cells.

Prexy Modi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.